Literature DB >> 18773493

Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis.

Yuanmei Lou1, Olena Preobrazhenska, Ulrich auf dem Keller, Margaret Sutcliffe, Lorena Barclay, Paul C McDonald, Calvin Roskelley, Christopher M Overall, Shoukat Dedhar.   

Abstract

Epithelial-mesenchymal transition (EMT) has been linked to metastatic propensity. The 4T1 tumor is a clinically relevant model of spontaneous breast cancer metastasis. Here we characterize 4T1-derived cell lines for EMT, in vitro invasiveness and in vivo metastatic ability. Contrary to expectations, 67NR cells, which form primary tumors but fail to metastasize, express vimentin and N-cadherin, but not E-cadherin. 4T1 cells express E-cadherin and ZO-1, but are migratory, invasive, and metastasize to multiple sites. 66cl4 cells form lung metastases and display a mixed phenotype, but are not as migratory or invasive as 67NR cells. These findings demonstrate that the metastatic ability of breast cancer cells does not strictly correlate with genotypic and phenotypic properties of EMT per se, and suggest that other processes may govern metastatic capability. Gene expression analysis of primary tumors did not identify differences in EMT markers, but did reveal candidate genes that may influence metastatic ability. Copyright (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18773493     DOI: 10.1002/dvdy.21658

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  57 in total

Review 1.  How to Choose a Mouse Model of Breast Cancer, a Genomic Perspective.

Authors:  Matthew R Swiatnicki; Eran R Andrechek
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-06-21       Impact factor: 2.673

2.  Snail1-dependent control of embryonic stem cell pluripotency and lineage commitment.

Authors:  Yongshun Lin; Xiao-Yan Li; Amanda L Willis; Chengyu Liu; Guokai Chen; Stephen J Weiss
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

3.  Dynamics of Tissue-Induced Alignment of Fibrous Extracellular Matrix.

Authors:  Alexandra S Piotrowski-Daspit; Bryan A Nerger; Abraham E Wolf; Sankaran Sundaresan; Celeste M Nelson
Journal:  Biophys J       Date:  2017-08-08       Impact factor: 4.033

4.  Transparent reporting of experimental parameters in assays measuring phenotypic steps in metastasis.

Authors:  Robin Boiy; Jonas Steenbrugge; Jan Van Deun; An Hendrix; Evelyne Meyer; Olivier De Wever
Journal:  Clin Exp Metastasis       Date:  2018-10-28       Impact factor: 5.150

5.  Mechanical compression drives cancer cells toward invasive phenotype.

Authors:  Janet M Tse; Gang Cheng; James A Tyrrell; Sarah A Wilcox-Adelman; Yves Boucher; Rakesh K Jain; Lance L Munn
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

6.  Single-molecule studies of classical and desmosomal cadherin adhesion.

Authors:  Andrew Vae Priest; Ramesh Koirala; Sanjeevi Sivasankar
Journal:  Curr Opin Biomed Eng       Date:  2019-09-28

7.  Vaccine-mediated immunotherapy directed against a transcription factor driving the metastatic process.

Authors:  Andressa Ardiani; Sofia R Gameiro; Claudia Palena; Duane H Hamilton; Anna Kwilas; Thomas H King; Jeffrey Schlom; James W Hodge
Journal:  Cancer Res       Date:  2014-02-11       Impact factor: 12.701

8.  Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer.

Authors:  K Lundgren; B Nordenskjöld; G Landberg
Journal:  Br J Cancer       Date:  2009-10-20       Impact factor: 7.640

9.  The microRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin.

Authors:  Brian Ell; Qiong Qiu; Yong Wei; Laura Mercatali; Toni Ibrahim; Dino Amadori; Yibin Kang
Journal:  J Biol Chem       Date:  2014-06-25       Impact factor: 5.157

10.  Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype.

Authors:  G Grelier; N Voirin; A-S Ay; D G Cox; S Chabaud; I Treilleux; S Léon-Goddard; R Rimokh; I Mikaelian; C Venoux; A Puisieux; C Lasset; C Moyret-Lalle
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.